UT San Antonio study evaluates rapamycin’s potential to promote healthy aging
UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Aging, the study will examine dosing, safety and long-term effects to help guide future research … Read more